CY1107547T1 - Συμπλοκα χρωμιου -ιστιδινης ως θρεπτικα συμπληρωματα - Google Patents
Συμπλοκα χρωμιου -ιστιδινης ως θρεπτικα συμπληρωματαInfo
- Publication number
- CY1107547T1 CY1107547T1 CY20071100019T CY071100019T CY1107547T1 CY 1107547 T1 CY1107547 T1 CY 1107547T1 CY 20071100019 T CY20071100019 T CY 20071100019T CY 071100019 T CY071100019 T CY 071100019T CY 1107547 T1 CY1107547 T1 CY 1107547T1
- Authority
- CY
- Cyprus
- Prior art keywords
- nutritional supplements
- chromium
- stein
- chrome
- complexes
- Prior art date
Links
- 235000015872 dietary supplement Nutrition 0.000 title abstract 3
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 abstract 2
- 238000010521 absorption reaction Methods 0.000 abstract 2
- 229910052804 chromium Inorganic materials 0.000 abstract 2
- 239000011651 chromium Substances 0.000 abstract 2
- 235000013305 food Nutrition 0.000 abstract 2
- HWWGNMFPCFUDTQ-JEDNCBNOSA-N (2s)-2-amino-3-(1h-imidazol-5-yl)propanoic acid;chromium Chemical compound [Cr].OC(=O)[C@@H](N)CC1=CN=CN1 HWWGNMFPCFUDTQ-JEDNCBNOSA-N 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 230000023852 carbohydrate metabolic process Effects 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 235000018823 dietary intake Nutrition 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 230000037356 lipid metabolism Effects 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F11/00—Compounds containing elements of Groups 6 or 16 of the Periodic Table
- C07F11/005—Compounds containing elements of Groups 6 or 16 of the Periodic Table compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/30—Oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Animal Husbandry (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- General Preparation And Processing Of Foods (AREA)
Abstract
Το χρώμιο είναι ένα ουσιώδες στοιχείο το οποίο έχει αποδειχθεί ότι έχει ευεργετικές επιδράσεις πάνω στο μεταβολισμό υδατανθράκων και λιπιδίων. Συχνά, η τροφική λήψη είναι υποβέλτιστη, και τα διατροφικά συμπληρώματα μπορούν να μην είναι αποτελεσματικά λόγω της μικρής απορρόφησης στο γαστρεντερικό σωλήνα. Εχει παρασκευαστεί ένα νέο σύμπλοκο χρωμίου-ιστιδίνης το οποίο βελτιώνει σημαντικά τη δυνατότητα απορρόφησης των σημερινών διαθέσιμων διατροφικών συμπληρωμάτων χρωμίου. Το σύμπλοκο είναι ασφαλές, παρασκευάζεται εύκολα και μπορεί να συνδυάζεται με ένα εδώδιμο φορέα για κατανάλωση ως ένα δισκίο, μια κάψουλα, ένα υδάτινο διάλυμα, τροφή ή προϊόν διατροφής.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/414,645 US6689383B1 (en) | 1999-10-08 | 1999-10-08 | Chromium-histidine complexes as nutrient supplements |
| EP00970641A EP1235835B1 (en) | 1999-10-08 | 2000-10-06 | Chromium-histidine complexes as nutrient supplements |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1107547T1 true CY1107547T1 (el) | 2013-03-13 |
Family
ID=23642324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20071100019T CY1107547T1 (el) | 1999-10-08 | 2007-01-08 | Συμπλοκα χρωμιου -ιστιδινης ως θρεπτικα συμπληρωματα |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6689383B1 (el) |
| EP (1) | EP1235835B1 (el) |
| JP (1) | JP4837214B2 (el) |
| AT (1) | ATE348834T1 (el) |
| AU (1) | AU779042B2 (el) |
| CA (1) | CA2386790C (el) |
| CY (1) | CY1107547T1 (el) |
| DE (1) | DE60032509T2 (el) |
| DK (1) | DK1235835T3 (el) |
| ES (1) | ES2277857T3 (el) |
| MX (1) | MXPA02003459A (el) |
| PT (1) | PT1235835E (el) |
| WO (1) | WO2001027123A1 (el) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7247328B2 (en) * | 2002-05-31 | 2007-07-24 | Zinpro Corporation | Chromium (III) alpha amino acid complexes |
| US20060029642A1 (en) | 2004-08-03 | 2006-02-09 | Dusan Miljkovic | Methods and compositions for improved chromium complexes |
| US7297686B2 (en) * | 2004-11-16 | 2007-11-20 | Hwang David L | Chromium complex with insulin-like activity |
| WO2007002739A2 (en) * | 2005-06-28 | 2007-01-04 | The University Of Wyoming | Chromium-amino acid complexes in the treatment of diabetes and other diseases |
| MX2008013190A (es) | 2006-04-12 | 2009-02-10 | Interhealth Nutraceuticals Inc | Compuestos de cromo trivalente, composiciones y metodos de uso. |
| AU2008210586B2 (en) * | 2007-01-31 | 2013-07-04 | Nutrition 21, Inc. | Use of chromium histidinate for treatment of cardiometabolic disorders |
| WO2008112706A1 (en) * | 2007-03-13 | 2008-09-18 | Nutrition 21, Inc. | Methods and compositions for the sustained release of chromium |
| WO2009002867A2 (en) | 2007-06-26 | 2008-12-31 | Nutrition 21, Inc. | Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement |
| EP4070801A1 (en) | 2011-03-01 | 2022-10-12 | Nutrition 21, LLC | Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders |
| GB2587289B (en) * | 2015-06-23 | 2021-06-23 | Jds Therapeutics Llc | Chromium Histidinate Complexes |
| MX2018009748A (es) | 2016-02-11 | 2019-02-07 | Nutrition 21 Llc | Composiciones que contienen cromo para mejorar la salud y el estado físico. |
| US10820617B1 (en) | 2018-03-29 | 2020-11-03 | Government Of The United States, As Represented By The Secretary Of The Air Force | All inclusive electrolytes, vitamins, and protein powder training supplement |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3925433A (en) | 1973-09-10 | 1975-12-09 | Zinpro Corp | 1:1 And 2:1 chromium, alpha amino acid complex salts |
| US4167564A (en) * | 1974-09-23 | 1979-09-11 | Albion Laboratories, Inc. | Biological assimilation of metals |
| NZ183858A (en) * | 1976-12-17 | 1979-10-25 | Ashmead Hh | Polyvalent metal proteinates as food additives |
| US4863898A (en) * | 1986-02-06 | 1989-09-05 | Albion International, Inc. | Amino acid chelated compositions for delivery to specific biological tissue sites |
| US4830716B1 (en) | 1986-07-03 | 1999-12-07 | Albion Int | Preparation of pharmaceutical grade amino acid chelates |
| US5614553A (en) | 1990-07-06 | 1997-03-25 | Albion Laboratories, Inc. | Composition and method for alleviating stress in warm-blooded animals |
| US5702718A (en) | 1995-07-25 | 1997-12-30 | K.E.R. Associates, Inc. | Method for applying metal-amino acid complexes as supplements to feed |
-
1999
- 1999-10-08 US US09/414,645 patent/US6689383B1/en not_active Expired - Lifetime
-
2000
- 2000-10-06 EP EP00970641A patent/EP1235835B1/en not_active Expired - Lifetime
- 2000-10-06 DE DE60032509T patent/DE60032509T2/de not_active Expired - Lifetime
- 2000-10-06 AT AT00970641T patent/ATE348834T1/de active
- 2000-10-06 JP JP2001530341A patent/JP4837214B2/ja not_active Expired - Lifetime
- 2000-10-06 MX MXPA02003459A patent/MXPA02003459A/es active IP Right Grant
- 2000-10-06 CA CA002386790A patent/CA2386790C/en not_active Expired - Lifetime
- 2000-10-06 PT PT00970641T patent/PT1235835E/pt unknown
- 2000-10-06 DK DK00970641T patent/DK1235835T3/da active
- 2000-10-06 WO PCT/US2000/027727 patent/WO2001027123A1/en not_active Ceased
- 2000-10-06 ES ES00970641T patent/ES2277857T3/es not_active Expired - Lifetime
- 2000-10-06 AU AU79990/00A patent/AU779042B2/en not_active Expired
-
2007
- 2007-01-08 CY CY20071100019T patent/CY1107547T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA02003459A (es) | 2002-08-20 |
| JP2003516935A (ja) | 2003-05-20 |
| ATE348834T1 (de) | 2007-01-15 |
| DE60032509T2 (de) | 2007-10-11 |
| EP1235835A1 (en) | 2002-09-04 |
| DE60032509D1 (de) | 2007-02-01 |
| EP1235835A4 (en) | 2004-09-22 |
| US6689383B1 (en) | 2004-02-10 |
| CA2386790A1 (en) | 2001-04-19 |
| AU779042B2 (en) | 2005-01-06 |
| JP4837214B2 (ja) | 2011-12-14 |
| CA2386790C (en) | 2009-07-14 |
| PT1235835E (pt) | 2007-01-31 |
| ES2277857T3 (es) | 2007-08-01 |
| AU7999000A (en) | 2001-04-23 |
| DK1235835T3 (da) | 2007-02-12 |
| WO2001027123A1 (en) | 2001-04-19 |
| EP1235835B1 (en) | 2006-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1107547T1 (el) | Συμπλοκα χρωμιου -ιστιδινης ως θρεπτικα συμπληρωματα | |
| Kumar | National nutritional anaemia control programme in India | |
| HUP0301386A3 (en) | Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill. the chronically ill and people with malnutrition | |
| BR9711278A (pt) | FÄrmula nutricional para pacientes com fenilcetonÚria | |
| MX2007011416A (es) | Composiciones de fucoidan y metodos para suplementos alimenticios y nutricionales. | |
| TR200201921T2 (tr) | İyileştirilmiş pediyatrik formülasyon ve beslenme temin etmek ve tolerans geliştirmek için yöntemler. | |
| DE69806820D1 (de) | Kaloriereiche ernährungszusammensetzung | |
| ATE471665T1 (de) | Nahrungsergänzungsmittel für hiv-patienten | |
| IT1311495B1 (it) | Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento. | |
| HK1061146A2 (en) | Food and beverages | |
| MXPA04003499A (es) | Utilizacion de cistationina. | |
| WO2005123108A3 (en) | Advanced vitamins and protein based nutritional supplements | |
| AU2633997A (en) | Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive | |
| Akhilender Naidu | Vitamin C in human health and disease is still a mystery? An overview. | |
| ATE217494T1 (de) | Orale darreichungsform | |
| CA2395530A1 (en) | Calcium formate for use as a phosphorus binder and a dietary supplement | |
| HUP0301568A3 (en) | Double offumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same | |
| Chan | The role of nutrients in modulating disease | |
| CA2620313A1 (en) | Nutritional method for elderly people | |
| Nguyen et al. | Got Rice? An Unusual Case of Iodine-Deficiency Hypothyroidism. | |
| WO1999037167A3 (en) | Process of improving the stability of vitamin d in a nutritional product containing hydrolyzed protein and product produced thereby | |
| WO2008066715A3 (en) | Method of treatment using aspergillus oryzae protease | |
| CN1069885A (zh) | 人体长久营养液的配方及生产工艺 | |
| Imran et al. | Complementary and alternative medicine iron preparations: A cost-effective, rationale and accessible solution for public health problems | |
| Mees et al. | Citric acid in calcium effervescent tablets may favour aluminium intoxication |